Content area
Full Text
Royal Philips and Banyan Biomarkers, Inc. have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care. The financial details of the agreement were not disclosed.
The collaboration unites Philips' strength in patient monitoring and...